Direct Phase II SBIR Grants to Support Biomedical Technology Development
Funding Number: PAR-14-088 Funding Type: PAR Release Date:February 5, 2014 Expiration Date:January 8, 2017 Web Site:http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html
The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization.